| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 04/26/2007 | WO2007019376A3 Methods and compositions for diagnosis of iga-and igm-mediated kidney diseases |
| 04/26/2007 | WO2007009638A3 Complexes containing perfluoroalkyl, method for the production and use thereof |
| 04/26/2007 | WO2007002332A3 Optical imaging contrast agents |
| 04/26/2007 | WO2006073441A3 High throughput assays for transmissible spongiform encephalopathies (tse) |
| 04/26/2007 | WO2006042724A3 Magnetic particles for therapy and diagnosis |
| 04/26/2007 | WO2005035441A3 Subtituted fullerene compositions and their use as antioxydants |
| 04/26/2007 | US20070092881 Gene markers of tumor metastasis |
| 04/26/2007 | US20070092549 Delivering magnetic antimitotic agent in manner more toxic to cancer than normal cells while maintaining high concentration for a sustained period of time |
| 04/26/2007 | US20070092510 Gene expression inhibition; drug screening; reduction of nociception; modulation of the activity and/or expression of a chloride transporter, such as the KCC2 potassium-chloride cotransporter |
| 04/26/2007 | US20070092451 Time indicating containers for dental compositions |
| 04/26/2007 | US20070092450 Tissue-specific exogenous optical agents |
| 04/26/2007 | US20070092449 Methods for direct visualization of active synapses |
| 04/26/2007 | US20070092448 Inhibitor screening method and atopic dermatitis-like symptom inducing method which utilizes induction of production of interleukin 18 by keratinocyte and utilization of same |
| 04/26/2007 | US20070092447 Contrast agent for combined modality imaging and methods and systems thereof |
| 04/26/2007 | US20070092446 Patient Selection Method For Assisting Weight Loss |
| 04/26/2007 | US20070092445 Assessing Ovarian Reserve |
| 04/26/2007 | US20070092444 Inhibition of inward sodium currents in cancer |
| 04/26/2007 | US20070090323 Ferrofluids stable in neutral media and modified ferrofluids modifies obtained by modification of the surface of the particles of said ferrofluids |
| 04/26/2007 | CA2625864A1 Transgenic ro s a26-luc i f eras e mice for bioluminescent imaging |
| 04/25/2007 | EP1776948A1 Method of producing liposome-containing preparation |
| 04/25/2007 | EP1776591A1 Diagnostic and therapeutic use of a plasma membrane atpase |
| 04/25/2007 | EP1776140A2 Methods of inhibiting viral replication |
| 04/25/2007 | EP1776139A2 Targeting damaged lung tissue |
| 04/25/2007 | EP1610671A4 Polarized light devices and methods |
| 04/25/2007 | EP1551478A4 Threaded syringe with quick stop |
| 04/25/2007 | EP1347731B1 In vivo multiphoton diagnostic detection and imaging of a neurodegenerative disease |
| 04/25/2007 | CN1953771A Perturbed membrane-binding compounds and methods of using the same |
| 04/25/2007 | CN1953770A X-ray visible drug delivery device |
| 04/25/2007 | CN1953757A Composition for cleaning intestinal canal |
| 04/25/2007 | CN1951506A Ultrasound and MRI combined contrast medium and preparation method thereof |
| 04/25/2007 | CN1951505A Mannitol contrast medium |
| 04/24/2007 | US7208525 Diagnostic agents for pancreatic exocrine function |
| 04/24/2007 | US7208140 Trimeric macrocyclic substituted benzene derivatives |
| 04/24/2007 | US7208139 Conducting nuclear spin tomography on a patient who has been administered a cascade polymer complex having complex-forming ligands for imaging of inflammation and/or tumors in the brain |
| 04/24/2007 | US7208138 Contrast enhancement agent for magnetic resonance imaging |
| 04/24/2007 | CA2242768C Activatable infusable dispersions and methods for using them for therapy and diagnostics |
| 04/24/2007 | CA2212113C Stabilized gas emulsion containing phospholipid for ultrasound contrast enhancement |
| 04/24/2007 | CA2120336C Detecting digeorge syndrome mutations |
| 04/24/2007 | CA2073855C Glycoalkaloids for controlling cellular autophagy |
| 04/19/2007 | WO2007044867A2 Imaging agents and methods of use thereof |
| 04/19/2007 | WO2007043202A1 Stable novel nitron compound and use thereof |
| 04/19/2007 | WO2007042833A2 Arnphiphilic nanotubes and micelles comprising same for use in the delivery of biologically active agents |
| 04/19/2007 | WO2007042775A2 Conjugates of photosensitisers and antibodies |
| 04/19/2007 | WO2007042641A1 Device and method for luminescence imaging |
| 04/19/2007 | WO2007009058A2 Contrast agents and methods for preparing contrast agents |
| 04/19/2007 | WO2006117166A3 Mri contrast agents endowed with concentration independent responsiveness |
| 04/19/2007 | WO2005111234A3 Methods of using zc1 and zc3 kinase substrate phosphorylation as biomarkers |
| 04/19/2007 | US20070089175 Mating a transgenic mouse whose genome encodes mouse perlecan, a large multidomain proteoglycan that binds and cross-links extracellular matrix (ECM) components and cell surface molecules, domains, with a second transgenic mouse whose genome encodes the human C terminal of A beta precursor protein |
| 04/19/2007 | US20070088087 Concentrated x-ray contrast media can act as universal antigens and can inhibit or prevent allergic reactions |
| 04/19/2007 | US20070087060 Ultrasound coupling medium for use in medical diagnostics |
| 04/19/2007 | US20070087046 Use of green porphyrins to treat neovasculature in the eye |
| 04/19/2007 | US20070087004 Pro104 antibody compositions and methods of use |
| 04/19/2007 | US20070086950 GAT2 transporters expressed in blood brain barrier cells |
| 04/19/2007 | US20070086949 Method of bioimaging using nanocrystals of fluorescent dyes |
| 04/19/2007 | US20070086948 Determining risk of tissue damage in ischemic tissue by administering a diagnostic imaging agent containing oxygen-17 in carrier (blood) and comparing the oxygen extraction fraction of a first tissue zone to the extraction fraction of a second tissue zone using proton magnetic resonance imaging |
| 04/19/2007 | US20070086947 System and Method for Selecting a Pillow and Mattress |
| 04/19/2007 | US20070086946 Assay |
| 04/19/2007 | US20070086945 Preparations for diagnosis of pancreatic exocrine function |
| 04/19/2007 | CA2625196A1 Compounds comprising a biological target recognizing part, coupled to a signal part capable of complexing gallium |
| 04/19/2007 | CA2624841A1 Conjugates of photosensitisers and antibodies |
| 04/18/2007 | EP1775307A2 Bispecific antibody effective to treat B-cell lymphoma and cell line |
| 04/18/2007 | EP1774978A1 Application of hyaluronic acid to sentinel lymph node identification |
| 04/18/2007 | EP1774332A2 Immune response assessment method |
| 04/18/2007 | EP1774028A1 Methods and compositions for treating obesity |
| 04/18/2007 | EP1773407A2 Nanoparticles with inorganic core and methods of using them |
| 04/18/2007 | EP1773406A2 Method for screening agents against human prostate disease |
| 04/18/2007 | EP1773405A2 Method of diagnosing, monitoring and treating pulmonary diseases |
| 04/18/2007 | EP1773404A2 Methylamine risks and treatment with n-derivatives of hyperactivity, depression and alcoholism |
| 04/18/2007 | EP1773402A2 Improved efficacy of immunotherapy by integrating diagnostic with therapeutic methods |
| 04/18/2007 | EP1773318A1 Combination anticancer therapy and pharmaceutical compositions therefor |
| 04/18/2007 | EP1562639B1 Method and arrangement for producing contrast agent for magnetic resonance imaging |
| 04/18/2007 | EP1434877B1 Chromogenic in situ hybridization methods, kits, and compositions |
| 04/18/2007 | EP1401479B1 Detection and therapy of vulnerable plaque with photodynamic compounds |
| 04/18/2007 | EP1254374B1 Method for diagnosing efficacy of xenotypic antibody therapy |
| 04/18/2007 | EP1248645B1 Novel chimeric proteins and their use |
| 04/18/2007 | EP0956865B1 MEDICINES COMPRISING Rho KINASE INHIBITOR |
| 04/18/2007 | CN1950111A Activatable particles, preparations and uses. |
| 04/18/2007 | CN1950100A Multi-component biological transport systems |
| 04/18/2007 | CN1948311A 2-iodine substituted phenyl-6-trifluoro methyl imidazole [1,2-a]-pyridine-3-acetamide compounds and its preparation method |
| 04/18/2007 | CN1947798A Method for preparing MRI visible, liver target and degradable nano-gene carrier |
| 04/18/2007 | CN1310652C Methods for pretreating a subject with extracorporeal photopheresis and/or apoptotic cells |
| 04/17/2007 | US7205343 Stabilized bioactive preparations and method of use |
| 04/17/2007 | US7205002 For causing a cell to die, for reducing intracellular glutathione, and sensitizing a cell to cytotoxic agents that the cell is resistant to due to the presence of intracellular glutathione |
| 04/17/2007 | CA2308721C Radio-opaque polymer biomaterials |
| 04/17/2007 | CA2178642C Metal ion-ligand coordination complexes, antibodies directed thereto, and assays using such antibodies |
| 04/12/2007 | WO2007041452A2 Methods for preparation of live body tissue for examination |
| 04/12/2007 | WO2007040506A1 High-purity texaphyrin metal complexes |
| 04/12/2007 | WO2007005491B1 Hydrazide conjugates as imaging agents |
| 04/12/2007 | WO2006032704A3 Diagnostic compounds for targeting a chemokine receptor |
| 04/12/2007 | WO2006023200A3 Cellular receptors utilized as carrier agents for pharmaceutical compounds used in tumor imaging and cancer treatment |
| 04/12/2007 | US20070082363 Using cardiovascular disorder plasma polypeptides (CPPs) as evaluative tools in detection coronary artery disease |
| 04/12/2007 | US20070081946 Assembly of gas-filled microvesicle with active component for contrast imaging |
| 04/12/2007 | US20070081945 Magnetic resonance imaging contrast agents |
| 04/12/2007 | US20070081944 Iontophoresis apparatus and method for the diagnosis of tuberculosis |
| 04/12/2007 | US20070081943 Alpha 4 beta 2 delta gaba-a receptors as a strategy for pms and alcoholism |
| 04/12/2007 | US20070081941 F-18 Labeled Amino Acid Analogs |
| 04/12/2007 | US20070080684 Method for the hyperpolarisation of atomic nuclei and device for carrying out said method |
| 04/12/2007 | CA2854550A1 Av.beta.6 peptide ligands and their uses |
| 04/12/2007 | CA2623334A1 High-purity texaphyrin metal complexes |
| 04/11/2007 | EP1772452A2 Matrix metalloproteinase inhibitors and uses thereof |